EREG and head and neck squamous cell carcinoma: Treatment with rhEREG (recombinant homo epiregulin) or autocrined EREG in conditioned medium (CM) both significantly increased PDL1 in different HNSCC cell lines (Fig. 1c, Supplementary Fig. 1s).